Cat. No.: DIA-0243344
Product Information | |
---|---|
CAS No. | 2736447-04-2 |
Formula | C31H30ClFN4O5 |
Molecular Weight | 593.05 |
SMILES | OC(C1=CC=C2C(N(C(CN3CCC(C4=C(O[C@](C(C=CC(Cl)=C5)=C5F)([H])CO6)C6=CC=C4)CC3)=N2)C[C@@H]7CCO7)=N1)=O |
Target | GCGR |
Product Description | GLP-1 receptor agonist 7 is a potent agonist of glucagon-like peptide-1 (GLP-1). GLP-1 receptor agonist 7 has the potential for the research of GLP-1-associated diseases, disorders, and conditions including diabetes mellitus (extracted from patent WO2021219019A1, compound 130b). |
Format & Storage | |
---|---|
Format | Solid |
Color | White to light yellow |
Purity | 98.41% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | In solvent: -80°C, 6 months; -20°C, 1 month (protect from light) |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.